FDA Confirms Cyber Vulnerability in Certain St. Jude Implantable Devices, But Notes New Software Patch

FDA Confirms Cyber Vulnerability in Certain St. Jude Implantable Devices, But Notes New Software Patch

The U.S. Food and Drug Administration has confirmed cybersecurity vulnerabilities in St. Jude Medical’s Merlin@home transmitter and radio frequency-enabled implantable cardiac devices, and has issued a Safety Alert containing recommendations for reducing the risk of cyber intrusions. Moreover, the FDA notes that St. Jude has developed and validated a software patch that addresses the identified vulnerabilities.  The patch became available this week, and will be applied automatically to the Merlin@home transmitter. [1/11/17]

Search